(4S)-4-[[(2S)-2-acetamido-3-carboxy-propanoyl]amino]-5-[[(1S)-1-[[(1S)-1-(carboxymethyl)-2,3-dioxo-propyl]carbamoyl]-2-methyl-propyl]amino]-5-oxo-pentanoic acid

ID: ALA4782926

PubChem CID: 101009379

Max Phase: Preclinical

Molecular Formula: C21H30N4O12

Molecular Weight: 530.49

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)C=O)C(C)C

Standard InChI:  InChI=1S/C21H30N4O12/c1-9(2)18(21(37)24-12(6-16(31)32)14(28)8-26)25-19(35)11(4-5-15(29)30)23-20(36)13(7-17(33)34)22-10(3)27/h8-9,11-13,18H,4-7H2,1-3H3,(H,22,27)(H,23,36)(H,24,37)(H,25,35)(H,29,30)(H,31,32)(H,33,34)/t11-,12-,13-,18-/m0/s1

Standard InChI Key:  LUOWSNAZOQEWCS-RSLFNQERSA-N

Molfile:  

 
     RDKit          2D

 37 36  0  0  0  0  0  0  0  0999 V2000
    7.0270  -11.6182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7398  -11.2036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7398  -10.3783    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4530  -11.6184    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1661  -11.2036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8834  -11.6184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5966  -11.2036    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.3097  -11.6184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0228  -11.2036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7401  -11.6184    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.4533  -11.2036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1664  -11.6184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8796  -11.2036    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5968  -11.6184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3100  -11.2036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0231  -11.6184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7404  -11.2036    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.3100  -10.3783    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.5968  -12.4436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3100  -12.8543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3100  -13.6796    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.0231  -12.4436    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.1664  -12.4436    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.4533  -10.3783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7401   -9.9677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1664   -9.9677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0228  -10.3783    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.3097  -12.4436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0228  -12.8543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0228  -13.6796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7401  -14.0901    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.3097  -14.0901    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8834  -12.4436    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.1661  -10.3783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8834   -9.9677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8834   -9.1424    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.6810  -10.1814    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 15 18  2  0
 14 19  1  6
 19 20  1  0
 20 21  1  0
 20 22  2  0
 12 23  2  0
 11 24  1  1
 24 25  1  0
 24 26  1  0
  9 27  2  0
  8 28  1  6
 28 29  1  0
 29 30  1  0
 30 31  1  0
 30 32  2  0
  6 33  2  0
  5 34  1  1
 34 35  1  0
 35 36  2  0
 35 37  1  0
M  END

Alternative Forms

  1. Parent:

Associated Targets(Human)

CASP3 Tchem Caspase-3 (3632 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 530.49Molecular Weight (Monoisotopic): 530.1860AlogP: -2.82#Rotatable Bonds: 17
Polar Surface Area: 262.44Molecular Species: ACIDHBA: 9HBD: 7
#RO5 Violations: 2HBA (Lipinski): 16HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.44CX Basic pKa: CX LogP: -2.70CX LogD: -12.23
Aromatic Rings: Heavy Atoms: 37QED Weighted: 0.07Np Likeness Score: 0.37

References

1. Bancet A,Raingeval C,Lomberget T,Le Borgne M,Guichou JF,Krimm I.  (2020)  Fragment Linking Strategies for Structure-Based Drug Design.,  63  (20.0): [PMID:32539387] [10.1021/acs.jmedchem.0c00242]

Source